Paid Clinical Trials in Texas

Texas has 5,331 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,648 clinical trials

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for Hepatitis B Virus Infection

Sites in San Antonio, Webster +9 more locations

Sponsor: GigaGen, Inc.

Sex: All·Age: 18+

Code: NCT07024641·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for Atopic Dermatitis

Sites in Dallas, San Antonio +20 more locations

Sponsor: Apogee Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07003425·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of DS5361b in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in San Antonio, Irving +3 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07182591·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

for REM Sleep Behavior Disorder

Sites in Houston, San Antonio +17 more locations

Sponsor: Yale University

Sex: All·Age: 50 - 80

Code: NCT06996652·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for Advanced or Metastatic Non-small Cell Lung Cancer

Sites in Tyler +8 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06996782·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Study of BHV-1400 in IgA Nephropathy

for IgA Nephropathy

Sites in Houston +13 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18 - 65

Code: NCT07054684·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for Prostate Cancer

Drug: Saruparib

Sites in Houston, San Antonio +36 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06952803·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

for Healthy Participants

Sites in San Antonio +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT06980428·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for Growth Hormone Deficiency (GHD)

Sites in San Antonio, Fort Worth +27 more locations

Sponsor: Lumos Pharma

Sex: All·Age: 3 - 11

Code: NCT06948214·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

for Chronic Kidney Disease

Sites in San Antonio +3 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07024823·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

for Primary Sjögren's Syndrome

Drug: IMVT-1402

Sites in Houston, San Antonio +27 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 74

Code: NCT06979531·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

for Asthma

Sites in Dallas, Austin +28 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 75

Code: NCT06932263·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for Parkinson Disease

Sites in Round Rock +14 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 40 - 80

Code: NCT06976268·Phase 2, Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for Proteinuric Kidney Disease

Drug: MZE829

Sites in Houston, Dallas +66 more locations

Sponsor: Maze Therapeutics

Sex: All·Age: 18 - 68

Code: NCT06830629·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Sites in Houston, Dallas +294 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for Advanced Breast Cancer

Drug: Camizestrant

Sites in Houston, San Antonio +36 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06380751·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Houston, Dallas +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

Sites in Houston, Dallas +115 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

for Acute Myeloid Leukemia, Adult

Drug: Venetoclax

Sites in Dallas +15 more locations

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All·Age: 18+

Code: NCT06652438·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for Solid Tumor

Drug: INBRX-106

Sites in Tyler +12 more locations

Sponsor: Inhibrx Biosciences, Inc

Sex: All·Age: 18+

Code: NCT04198766·Phase 1, Phase 2·Recruiting·Listed Dec 2019

Apply to this trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for Gastric Cancer

Sites in Houston +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06219941·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for Pulmonary Arterial Hypertension

Sites in Houston, Dallas +27 more locations

Sponsor: Gossamer Bio USA, Inc.

Sex: All·Age: 18 - 75

Code: NCT06274801·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

for Malignant Peripheral Nerve Sheath Tumor (MPNST)

Sites in Dallas +1 more location

Sponsor: AeRang Kim

Sex: All·Age: 18+

Code: NCT06735820·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for Transthyretin Amyloidosis

Sites in Dallas +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06465810·Recruiting·Listed Jun 2024

Apply to this trial

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for Binge-Eating Disorder

Drug: Solriamfetol

Sites in Dallas, San Antonio +36 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 55

Code: NCT06413433·Phase 3·Recruiting·Listed May 2024

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in Houston, Dallas +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for Hepatocellular Carcinoma

Drug: Rilvegostomig

Sites in Houston, San Antonio +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06921785·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

for Psychosis Associated With Alzheimer's Disease

Sites in McKinney, Sugarland +29 more locations

Sponsor: MapLight Therapeutics

Sex: All·Age: 55 - 90

Code: NCT06887192·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for Metastatic Clear Cell Renal Cell Carcinoma

Drug: Cabozantinib

Sites in Dallas, Lubbock +40 more locations

Sponsor: Arcus Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07011719·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for Ulcerative Colitis (UC)

Sites in Houston, San Antonio +27 more locations

Sponsor: Xencor, Inc.

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT06619990·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for Excessive Sleepiness

Drug: Solriamfetol

Sites in Houston, San Antonio +39 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 65

Code: NCT06568367·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for Metastatic Malignant Solid Neoplasm

Sites in Houston +17 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05372614·Phase 1·Recruiting·Listed May 2022

Apply to this trial

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

for Obsessive Compulsive Disorder (OCD)

2 locations in Houston

Sponsor: Baylor College of Medicine

Sex: All·Age: 22 - 64

Code: NCT06596447·Recruiting·Listed Sep 2024

Apply to this trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Sites in Houston +18 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 95

Code: NCT05061550·Phase 2·Recruiting·Listed Sep 2021

Apply to this trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for Ovarian Cancer

Sites in Houston +9 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05797168·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

for Asthma

Sites in Houston, Dallas +19 more locations

Sponsor: AstraZeneca

Sex: All·Age: 5 - 11

Code: NCT06023589·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for Heart Failure

Drug: Finerenone

Sites in Houston, Austin +31 more locations

Sponsor: Colorado Prevention Center

Sex: All·Age: 18+

Code: NCT06024746·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

for Gastrointestinal Neoplasms

Sites in Houston, San Antonio +10 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06885034·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

for Transverse Myelitis

1 location in Dallas

Sponsor: Q Therapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT03887273·Phase 1, Phase 2·Recruiting·Listed Mar 2019

Apply to this trial

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

for Advanced Malignant Solid Neoplasm

Sites in Houston & Galveston

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05111561·Phase 1·Recruiting·Listed Nov 2021

Apply to this trial